|
시장보고서
상품코드
2075119
바이오의약품 아웃소싱 시장 : 제품 유형 및 서비스 유형별, 조달원별, 용도별, 최종사용자별 및 지역별Biologics Outsourcing Market, By Product and Service Type, By Source, By Application By End User, and By Region |
||||||
바이오의약품 아웃소싱 시장은 2026년에 283억 7,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 671억 5,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 13.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 283억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 13.10% | 2033년 시장 규모 예측 : | 671억 5,000만 달러 |
바이오의약품이란 인간, 동물 또는 미생물의 세포를 포함한 천연 유래 원료로 제조되는 의약품으로, 탄수화물, 단백질 또는 핵산으로 구성되어 있습니다. 또한 바이오의약품에는 인체 세포 및 조직, 생백신, 알레르겐 추출물, 세포·유전자 치료제 등이 포함됩니다. 바이오의약품은 만성질환이나 심혈관 질환 등의 치료에 사용되고 있습니다.
바이오의약품 업계의 급속한 발전에 더해, 바이오의약품 기업의 사내 개발·제조 능력이나 체계가 미흡하거나 아예 갖추어지지 않은 탓에, 각 제약사는 바이오의약품 개발 및 제조 공정의 각 단계를 고효율적인 서비스 제공 기업에 외주 맡길 수밖에 없었습니다. 대형 제약 기업은 자사의 핵심 역량에 집중하는 한편, 운영 비용을 절감하기 위해 바이오의약품 제조를 CRO(의약품 개발 수탁 기관)나 CMO(의약품 제조 수탁 기관) 등에 위탁하고 있습니다.
시장 역학
주요 시장 참여자들은 제품 포트폴리오를 강화하기 위한 제휴 등 비유기적 성장 전략에 주력하고 있으며, 이는 예측 기간 중 전 세계 바이오의약품 아웃소싱 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2021년 11월, 엔드투엔드 CDMO 서비스를 제공하는 GenScript Biotech Corporation의 자회사인 GenScript ProBio는 치료용 및 진단용 모노클로널 항체(mAb)의 세포주 개발, 원료의약품 및 제제 제조에 관한 계약을 체결했다고 발표했습니다.
주요 시장 참여자들은 자사의 서비스 및 제품 포트폴리오를 강화하기 위한 시설 확장에 주력하고 있으며, 이는 예측 기간 중 전 세계 바이오의약품 아웃소싱 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2022년 12월, 제약 기업인 Catalent, Inc.는 노스캐롤라이나주 리서치 트라이앵글내 잉글랜드 더럼에 새로운 바이오의약품 분석 센터 오브 엑셀런스를 설립하고, 세포 치료 및 유전자 치료를 포함한 바이오의약품 모달리티를 대상으로 포괄적인 독립형 분석 개발 및 시험 서비스를 제공할 것이라고 발표했습니다. 이 회사는 80,000제곱피트 규모의 시설에 자동화 및 디지털화 기능을 포함한 장비와 설비를 도입하기 위해 최대 4,000만 달러를 투자할 계획입니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)을 바탕으로 전 세계 바이오의약품 아웃소싱 시장의 주요 기업 개요을 소개하고 있습니다. 본 조사에서 다룬 주요 기업으로는 Thermo Fisher Scientific Inc., Abzena Ltd. Fujifilm Diosynth Biotechnologies, KBI Biopharma, EirGenix, Inc., Curia Global, Inc., Bionova Scientific, Inc., Boehringer Ingelheim International GmbH., STC Biologics., Abbvie Inc., Avid Bioservices, Inc., Catalent Inc., Emergent, Eurofins Scientific, Genentech, Inc., Genscript Biotech Corporation, JSR Corporation, Lonza, Merck KGaA, Rentschler Biopharma SE. 등이 있습니다.
- 이 보고서의 인사이트를 활용함으로써, 각 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 세계의 바이오의약품 아웃소싱 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 바이오의약품 아웃소싱 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 바이오의약품 아웃소싱 시장 : 제품·서비스 유형별, 2021-2033년
제5장 세계의 바이오의약품 아웃소싱 시장 : 소스별, 2021-2033년
제6장 세계의 바이오의약품 아웃소싱 시장 : 용도별, 2021-2033년
제7장 세계의 바이오의약품 아웃소싱 시장 : 최종사용자별, 2021-2033년
제8장 세계의 바이오의약품 아웃소싱 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.07.07Biologics Outsourcing Market is estimated to be valued at USD 28.37 Bn in 2026 and is expected to reach USD 67.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 28.37 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.10% | 2033 Value Projection: | USD 67.15 Bn |
Biologics are the drugs generated from natural sources including human, animal, or microbial cells and consist of carbohydrates, proteins, or nucleic acids. Moreover, biologics include human cells and tissues, live attenuated microbes, allergenic extracts, cell and gene treatments. Biologics medicines are available for the treatment of disease such as chronic disease, cardiovascular disease, and so on.
Pharmaceutical companies had to outsource different stages of the biologic development and manufacturing process to highly effective service provider organizations due to the fast-paced nature of the biologic industry and the insufficient or absence of internal biologic development and manufacturing capabilities and capacities of biopharmaceutical companies. Major pharmaceutical corporations outsource the production of biologics to contract research organizations, contract manufacturing organizations, and others in order to concentrate on their core competencies while reducing operational costs.
Market Dynamics
Key market players are focused on inorganic strategies such as agreements to strengthen its product portfolio, is expected to drive the growth of global biologics outsourcing market over the forecast period. For instance, in November 2021, GenScript ProBio, a subsidiary of GenScript Biotech Corporation offering end-to-end CDMO services, announced that the company had entered into an agreement for cell line development, drug substance, and drug product manufacturing of therapeutic and diagnostic monoclonal antibodies (mAbs).
Key market players is focused on facility expansion to strengthen the company's service and product portfolio, is expected to propel the growth of global biologics outsourcing market over the forecast period. For instance, in December 2022, Catalent, Inc. a pharmaceutical company, announced that it is establishing a new biologics analytical center of excellence in Durham, England, within North Carolina's Research Triangle, to offer comprehensive standalone analytical development and testing for biologic drug modalities, including cell and gene therapies. The company planned to invest up to US$ 40 million to fit the 80,000 square-foot facility with equipment and instrumentation, including automation and digitization capabilities
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global biologics outsourcing market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Abzena Ltd. Fujifilm Diosynth Biotechnologies, KBI Biopharma, EirGenix, Inc., Curia Global, Inc., Bionova Scientific, Inc., Boehringer Ingelheim International GmbH., STC Biologics., Abbvie Inc., Avid Bioservices, Inc., Catalent Inc., Emergent, Eurofins Scientific, Genentech, Inc., Genscript Biotech Corporation, JSR Corporation, Lonza, Merck KGaA, Rentschler Biopharma SE.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global biologics outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics outsourcing market
Detailed Segmentation:
- Global Biologics Outsourcing Market, By (Revenue, USD Bn, 2021 - 2033)Product and Service Type:
- Product
- Antibodies
- Recombinant Proteins
- Vaccines
- Others
- Services
- Cell Development
- Process Development
- Analytical Testing
- cGMP Manufacturing
- Others
- Global Biologics Outsourcing Market, By Source (Revenue, USD Bn, 2021 - 2033)
- Mammalian
- Microbial
- Global Biologics Outsourcing Market By Application:
- Oncology
- Cellular and Gene Therapy
- Blood & Blood-Related Products Development
- Vaccine Development
- Stem Cell Research
- Others
- Global Biologics Outsourcing Market By End User:
- Pharmaceutical Industries
- Biotechnology Industries
- CDMO
- Global Biologics Outsourcing Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country:
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- Thermo Fisher Scientific Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abzena Ltd.
- Fujifilm Diosynth Biotechnologies
- KBI Biopharma,
- EirGenix, Inc.
- Curia Global, Inc.
- Bionova Scientific, Inc.
- Boehringer Ingelheim International GmbH.
- STC Biologics.
- Abbvie Inc.
- Avid Bioservices, Inc.
- Catalent Inc.
- Emergent
- Eurofins Scientific
- Genentech, Inc.
- Genscript Biotech Corporation
- JSR Corporation
- Lonza
- Merck KGaA
- Rentschler Biopharma SE.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product and Service Type
- Market Snapshot, By Source
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- Service Cost Analysis
4. Global Biologics Outsourcing Market, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Product
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Antibodies
- Recombinant Proteins
- Vaccines
- Others
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Cell Development
- Process Development
- Analytical Testing
- cGMP Manufacturing
- Others
5. Global Biologics Outsourcing Market, By Source, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Microbial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
6. Global Biologics Outsourcing Market, By Application, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Cellular and Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Blood & Blood-Related Products Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Stem Cell Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
7. Global Biologics Outsourcing Market, By End User, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- Pharmaceutical Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Biotechnology Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- CDMO
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
8. Global Biologics Outsourcing Market, By Region, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abzena Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fujifilm Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- KBI Biopharma, EirGenix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- EirGenix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Curia Global, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bionova Scientific, Inc.
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH.
- Company Highlights
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- STC Biologics.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbvie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Avid Bioservices, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Catalent Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Emergent
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genentech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genscript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- JSR Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rentschler Biopharma SE.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
